NABERGOJ, MITJA
NABERGOJ, MITJA
Combination of eutos score and 3-month bcr-abl transcript level identifies a group of good-risk chronic myeloid leukemia patients with favourable response to frontline imatinib therapy.
2015 Tiribelli, M; Binotto, Gianni; Calistri, E; Maino, Elena; Scaffidi, L; Medeot, M; Nabergoj, Mitja; Ambrosetti, A; Semenzato, GIANPIETRO CARLO; Fanin, R; Bonifacio, M; Gruppo Triveneto, L. M. C.
Diagnostic and prognostic value of low percentage of glycosylated ferritin in acquired hemophagocytic lymphohistiocytosis: A single-center study
2017 Nabergoj, M.; Marinova, M.; Binotto, G.; Brugnaro, Luca; Zaninotto, M.; Plebani, M.; Semenzato, G.; Vianello, F.
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents
2017 Schiavinato, Alvise; Zanetto, Alberto; Pantano, G; Tosato, Francesca; Nabergoj, Mitja; Fogar, Paola; Piva, Elisa; Gambato, Martina; Franceschet, Enrica; Floreani, Annarosa; Farinati, Fabio; Burra, Patrizia; Russo, FRANCESCO PAOLO; Plebani, Mario
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine
2018 Scapinello, Greta; Pizzi, Marco; Vio, Stefania; Nabergoj, Mitja; Visentin, Andrea; Martines, Annalisa; Bonaldi, Laura; Trentin, Livio; Semenzato, Gianpietro; Piazza, Francesco